top of page
All Posts


Clinical Management of Synthetic-Cannabinoid-Induced Psychosis: A Systematic Review of Treatment Strategies and Outcomes
Understanding "Spice"-Induced Psychosis: A New Clinical Frontier Synthetic cannabinoid receptor agonists (SCRAs), often sold under street names like "Spice" or "K2," have become a global public health concern due to their potent and often unpredictable psychiatric effects. Unlike natural cannabis, these laboratory-engineered molecules bind to brain receptors with much higher affinity, frequently triggering acute psychotic episodes characterized by severe agitation, aggression
rajaduttamd
Apr 231 min read


Methamphetamine-Associated Cardiomyopathy
Methamphetamine use has emerged as a global public health crisis, second only to cannabis in its prevalence of abuse. While the drug is well-known for its stimulant properties on the central nervous system, its devastating impact on the heart—specifically methamphetamine-associated cardiomyopathy (MAC)—is increasingly reported yet remains under-studied. Clinically, MAC often presents as dilated cardiomyopathy, characterized by enlarged cardiac chambers and a severely reduced
rajaduttamd
Apr 231 min read


Managing Alcohol Withdrawal in General Hospitals
The COVID-19 pandemic triggered an unprecedented surge in alcohol consumption, leading to a significant rise in hospitalizations for alcohol withdrawal syndrome (AWS) . For patients admitted to general hospitals, the sudden interruption of alcohol intake creates an iatrogenic risk for withdrawal, which can range from mild anxiety and tremors to life-threatening conditions like seizures and delirium tremens . Effective management begins with universal screening using validate
rajaduttamd
Mar 292 min read


Cholinergic Rebound in Clozapine Withdrawal
While withdrawal symptoms from typical antipsychotics are generally mild and self-limiting, clozapine discontinuation can trigger a severe clinical picture characterized by rapid-onset agitation, delirium, and psychosis. Research into three specific case reports highlights that these symptoms often manifest within days of stopping the medication. Patients may experience a clouding of consciousness, disorientation, and even physical complications like profuse diaphoresis, inco
rajaduttamd
Mar 21 min read


Quetiapine vs. Haloperidol: A New Look at Managing ICU Delirium
Delirium remains a significant challenge in intensive care units, affecting nearly 32% of all critically ill patients and surging as high as 91% for those on mechanical ventilation. While haloperidol has traditionally served as the first-line treatment, its association with distressing extrapyramidal side effects and severe sedation has led researchers to explore safer alternatives. A recent randomized controlled trial published in Neurocritical Care investigated whether que
rajaduttamd
Feb 181 min read


Psychological consequences of female genital mutilation: A mixed-method systematic review
This mixed-method systematic review by Reman et al. (2023) investigates the significant mental health burden associated with female genital mutilation/cutting (FGM/C). By analyzing 14 studies published between 2010 and 2020, the researchers found that women who have undergone FGM/C experience a significantly higher prevalence of psychological disorders compared to those who have not. The primary clinical diagnoses identified include post-traumatic stress disorder (PTSD), depr
rajaduttamd
Feb 71 min read


Treatment outcomes in functional neurological disorder: a systematic review and meta-analysis exploring the influence of symptom chronicity
Conversion disorder—now termed Functional Neurological Disorder (FND) —has long been viewed through a pessimistic lens, particularly when symptoms persist over time. A major 2025 systematic review and meta-analysis in BMJ Neurology Open challenges that assumption by examining whether symptom chronicity actually limits treatment response . Drawing on 63 studies (27 included in meta-analyses, 885 patients), the authors evaluated outcomes across functional motor disorders,...
rajaduttamd
Jan 81 min read


Reducing Mortality with ECT: New Insights from a Global Meta-Analysis
Electroconvulsive therapy (ECT) has long been recognized as a powerful tool for treatment-resistant mood disorders, but its impact on long-term survival has remained a subject of clinical debate. A comprehensive new systematic review and meta-analysis published in BMJ Mental Health provides clear evidence that ECT is associated with a 30% reduction in the risk of all-cause mortality among patients with severe unipolar or bipolar depression. This protective effect was found
rajaduttamd
Jan 31 min read


Characteristics of high-dose benzodiazepine use: nationwide cohort study on new benzodiazepine users with 5-year follow-up
The Hidden Risks of Dose Escalation A new nationwide register-based study from Finland offers a sobering look at how often new benzodiazepine prescriptions spiral into high-dose usage. Following nearly 50,000 adults who initiated treatment in 2006, researchers tracked their usage patterns over five years and found that dose escalation is alarmingly common. While clinical guidelines universally recommend keeping doses low and durations short, the study revealed that 25.5% of
rajaduttamd
Dec 27, 20252 min read


The Impact of Preexisting Severe Mental Disorders on Cancer Mortality: A Systematic Review and Meta-Analysis (Riis et al., 2025)
A significant new meta-analysis published in Acta Psychiatrica Scandinavica has cast a stark light on a major health disparity: the survival gap for cancer patients who have pre-existing severe mental disorders (SMD). Analyzing data across 25 major studies, researchers determined that patients with pre-existing SMD face a 37% higher relative risk of dying from cancer compared to the general population. Crucially, the study found that this risk is most pronounced for individu
rajaduttamd
Dec 27, 20251 min read


💊 Antidepressant Use in Bipolar Depression: A Clinical Controversy
Antidepressants are frequently prescribed for bipolar disorder in clinical practice, despite poor scientific evidence supporting their efficacy for bipolar depression. Depressive episodes in bipolar disorder are particularly challenging due to their high prevalence, greater impairment in psychosocial and cognitive functioning, increased risk of suicide, and complex treatment. While a systematic review and network meta-analysis by Yildiz et al. suggested antidepressants might
rajaduttamd
Dec 11, 20252 min read


The Hidden Crisis
A major nationwide cohort study conducted in Sweden has shed critical light on the severe, yet often overlooked, risk of suicide among individuals who have been discharged from involuntary psychiatric care (IPC) . The research, which analyzed data from 72,275 patients treated in IPC between 2010 and 2020, aimed to provide the first comprehensive description of this vulnerable population. The findings underscore the fact that involuntary treatment, while necessary in acute sit
rajaduttamd
Dec 9, 20252 min read


Adjunctive Valproic Acid for Delirium and/or Agitation on a Consultation-Liaison Service
The clinical and research report details the adjunctive use of valproic acid (VPA) in six patients seen by a consultation-liaison service (CLS) for managing delirium and/or psychotic agitation. All six patients had suboptimal responses or concerning side effects when treated with conventional therapies like benzodiazepines and/or antipsychotics. In all cases, the addition of valproic acid to the conventional antidelirium medications led to improved control of behavioral sympt
rajaduttamd
Dec 8, 20252 min read


Taking back control: maintaining professional autonomy as psychiatrists
Psychiatrists today face increasing pressures that threaten their professional autonomy—pressures driven by resource constraints, managerial structures, and the growing distance between clinicians and decision-making environments. As highlighted in the article’s opening discussion (page 1), autonomy and a sense of mastery are essential for motivation, work satisfaction, and protection against burnout. Yet recent decades have seen a steady decline in physicians’ joy in clinic
rajaduttamd
Dec 4, 20252 min read


Nowhere to go: An overview of maternity care access across the U.S․
The Growing Crisis of Maternity Care Deserts The United States is currently facing a severe gap in maternal healthcare, with over 35% of counties designated as "maternity care deserts"—areas that completely lack obstetric clinicians and birthing facilities. These "no-access" counties are home to more than 2.3 million reproductive-aged women and account for over 150,000 births annually. The impact of this shortage is largely geographic; residents in rural counties are signifi
rajaduttamd
Nov 27, 20252 min read


Antipsychotics and Breast Cancer: Navigating the Prolactin Connection
The relationship between taking antipsychotic medication and the risk of developing breast cancer has been a consistent topic of research, with large-scale meta-reviews offering a clearer, yet complex, picture. A systematic review and meta-analysis of observational studies, which included over 2 million individuals, found a moderate association between antipsychotic use and breast cancer. The pooled Hazard Ratio (HR) from cohort studies was 1.39 (95% CI 1.11–1.73), suggestin
rajaduttamd
Nov 20, 20252 min read


Topiramate vs. Naltrexone: A Head-to-Head Showdown for AUD Treatment
A major question in addiction medicine has been how the widely used, but off-label, medication Topiramate stacks up against the established first-line treatment, Naltrexone , for Alcohol Use Disorder (AUD). A large, double-blind, genotype-stratified RCT, published in 2024, now provides the clearest answer yet 1111 . 🥊 The Main Event: Topiramate Is a Serious Contender The study found that Topiramate (up to $200 \text{ mg}/\text{day}$) is at least as effective and safe as Nal
rajaduttamd
Nov 10, 20252 min read


“Transdiagnostic effectiveness and safety of clozapine in individuals with psychotic, affective, and personality disorders: nationwide and meta-analytic comparisons with other antipsychotics”
Key details Population & design : The authors combined nationwide register-based cohorts (from Finland and Sweden) with a meta-analysis of existing literature. The cohort component included individuals aged ≥16 years with diagnoses across psychotic, affective, and personality disorders. thelancet.com +1 Intervention and comparator : The focus was on the use of Clozapine and comparisons were made to other antipsychotics (standard treatment) in terms of effectiveness and safet
rajaduttamd
Nov 8, 20252 min read


Navigating the Schizophrenia Treatment Maze: Are European Psychiatrists Following the Map?
A recent study shed light on the real-world treatment preferences of European psychiatrists for schizophrenia and compared them to existing clinical guidelines . The findings reveal a landscape of both consensus and significant divergence from recommended best practices, highlighting a critical need to bridge the gap between research and the clinic. 💊 Pharmacological Choices: Where Clinicians Agree (Mostly) The survey, which collected data from 454 psychiatrists and train
rajaduttamd
Nov 7, 20252 min read


The Summer of 1816: “The Year Without a Summer”
In 1816, after the eruption of Mount Tambora caused global climate chaos, Byron rented Villa Diodati on Lake Geneva. His guests included Mary Godwin (later Shelley) , Percy Bysshe Shelley , and Byron’s physician, John Polidori . Confined indoors by storms, the group challenged each other to write ghost stories. From that night’s creative experiment came Mary Shelley’s Frankenstein —conceived in a fevered dream about “the pale student of unhallowed arts kneeling beside the th
rajaduttamd
Oct 31, 20252 min read
bottom of page
